Navigation Links
MSC Names Paul Bode as Senior Vice President, Ancillary Sales
Date:12/28/2007

JACKSONVILLE, Fla., Dec. 28 /PRNewswire/ -- Medical Services Company (MSC), a leader in providing medical products and services to the workers' compensation industry, has named Paul Bode as Senior Vice President, Ancillary Sales. Bode will be responsible for overseeing a national sales force in MSC's ancillary sector.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050912/FLM025LOGO )

Bode has an extensive background in the workers' compensation industry. He previously served as Vice President, Sales & Marketing at Gould & Lamb, LLC where he was responsible for managing a national sales force as well as the marketing department. Prior to his experience with Gould & Lamb, Bode served in positions with GAB Robins, CompManagement, Inc., GENEX Services, Inc., and Sullivan Health Management. Bode holds a B.S. in Agricultural Economics from Texas A&M University.

"I am thrilled to welcome Paul Bode to the MSC executive team," said Joe Delaney, President and CEO of MSC. "His many years of sales leadership experience in the workers' compensation industry will be an invaluable asset to our company and our customers."

About MSC:

MSC provides medical products and services to the workers' compensation industry. Our customers include the nation's leading workers' compensation insurers, third-party administrators, and self-insured employers. Focusing exclusively on workers' compensation cases, MSC has fine-tuned the process to make working with them the most cost-efficient experience in the industry. MSC provides true one-stop service for its customer.


'/>"/>
SOURCE Medical Services Company, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... QualDerm Partners , a ... today announced Cumberland Skin Surgery and Dermatology has joined the company ... in both Hermitage and Lebanon, Tennessee, provides comprehensive general dermatology and skin cancer ...
(Date:8/16/2017)... Island, NY (PRWEB) , ... August 16, 2017 , ... ... with IV starts and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical ... takes much of the guesswork out of a needle stick and more importantly, helps ...
(Date:8/16/2017)... ... August 16, 2017 , ... Paul Vitenas, MD, FACS , is honored ... The annual list identifies the nation’s top physicians, in a variety of specialties. This ... the top of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted ...
(Date:8/16/2017)... ... , ... A global leader in the treatment of clubfoot, CURE International ... states—bringing the country one step closer to eliminating clubfoot as a lifelong disability by ... track to enroll 10,000 children in the clubfoot treatment program in this year alone. ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... states: “Drying the endoscope after every reprocessing cycle, both between patient procedures and ... and nosocomial infections. Drying is as important to the prevention of disease transmission ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/28/2017)... 2017 EnvoyHealth, a Diplomat company, has partnered with ... CleverCap LITE, a technology designed to improve patient medication ... health technology solutions and services that help track and ... CleverCap LITE offers medication monitoring and control for ... Records date and time ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: